Edivoxetine Hydrochloride is a selective norepinephrine reuptake inhibitor investigated primarily as a treatment for attention-deficit hyperactivity disorder and depression. As a chiral compound, this… Read more
Edivoxetine Hydrochloride is a selective norepinephrine reuptake inhibitor investigated primarily as a treatment for attention-deficit hyperactivity disorder and depression. As a chiral compound, this pharmaceutical agent is studied for its efficacy in modulating neurotransmitter levels. The associated reference standards, including pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope-labelled compounds, are critical components for researchers and analytical chemists. Laboratories utilize these high-quality materials to perform rigorous impurity profiling, conduct method validation, and ensure precise quality control during the drug development process. By providing characterized standards that mirror the active pharmaceutical ingredient, these products enable the quantification of unknown compounds and the verification of analytical methods. This comprehensive collection supports the necessary testing protocols required to maintain regulatory compliance and drug integrity throughout pharmaceutical research and development workflows.